Skip to main content
. Author manuscript; available in PMC: 2015 Feb 28.
Published in final edited form as: Cancer Lett. 2013 Oct 4;343(2):224–231. doi: 10.1016/j.canlet.2013.09.037

Figure 4.

Figure 4

Chemosensitization of MDA MB-231(A), SKOV3 (B), and SKOV3-tr (C) cells mediated by the pre-treatment with survivin siRNA PM. Cells were incubated with survivin siRNA PM (range of siRNA concentrations from 200 to 17.5 nM) for 6 h. Forty eight hours later, cells were challenged with various concentrations of PXL. The viability of cells was measured 24 h later by the CTB assay. Data = mean ± SD (n =3).**p < 0.01, and ***p < 0.001 values were obtained by comparing survivin siRNA PM pre-treated cells (survivin siRNA PM) to PXL no pre treated cells (no pre-treatment).